This is the authors' abstract. We don't add key points for this paper.
A. ObjectiveLangerhan cell histiocytosis (LCH) has varied presentation and significant advances in the recognition of risk organ involvement and optimising treatment duration have resulted in improved outcomes.We present here a case series of LCH involving unusual sites and innovative treatment strategies. B. DesignWe retrospectively analysed the data on children diagnosed to have LCH involving unusual sites with onset of symptoms, the management and outcomes in our department. C. ResultChild 1 presented with headache, torticollis and CT brain was suggestive of clival mass, underwent transnasal endoscopic excision, confirmed as LCH and was started on LCH protocol as per group 3 (special site) as skeletal survey was normal.She had diabetes insipidus and is on desmopressin.Child 2 presents with recurrent blood stained stools, failure to thrive, endoscopy was done which revealed moderate to severe patchy colitis, mild duodenitis, biopsy confirmed LCH.She received induction followed by continuation phase as PET CT confirmed her remission.However, in 3 months again she had recurrence of symptoms.She was started on salvage chemotherapy lenalidomide and dexamethasone.She received 3 cycles so far and is in partial remission .
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ganatra et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: